GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • SAGE Publications  (5)
  • 1
    Online Resource
    Online Resource
    SAGE Publications ; 2006
    In:  Annals of Pharmacotherapy Vol. 40, No. 7-8 ( 2006-07), p. 1480-1480
    In: Annals of Pharmacotherapy, SAGE Publications, Vol. 40, No. 7-8 ( 2006-07), p. 1480-1480
    Type of Medium: Online Resource
    ISSN: 1060-0280 , 1542-6270
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2006
    detail.hit.zdb_id: 2053518-1
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    SAGE Publications ; 2008
    In:  Primary Dental Care Vol. os15, No. 2 ( 2008-04), p. 76-76
    In: Primary Dental Care, SAGE Publications, Vol. os15, No. 2 ( 2008-04), p. 76-76
    Type of Medium: Online Resource
    ISSN: 1355-7610 , 1741-9344
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2008
    detail.hit.zdb_id: 2140166-4
    detail.hit.zdb_id: 2704369-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    SAGE Publications ; 2012
    In:  Journal of Oncology Pharmacy Practice Vol. 18, No. 2 ( 2012-06), p. 245-249
    In: Journal of Oncology Pharmacy Practice, SAGE Publications, Vol. 18, No. 2 ( 2012-06), p. 245-249
    Abstract: Purpose: The purpose of this review article is to describe the recent data supporting the use of epidermal growth factor receptor (EGFR) receptor tyrosine kinase inhibitors (TKIs) in the first-line setting of EGFR mutation-positive non-small cell lung cancer (NSCLC). Summary: EGFR receptor TKIs were originally developed in unselected NSCLC patients and demonstrated modest clinical benefit compared to placebo. With the discovery of improved benefits in the approximately 16% of NSCLC patients with an EGFR mutation, trials in selected populations were undertaken, demonstrating comparable efficacy to standard chemotherapy with an improved toxicity profile. The most common toxicity is rash, sometimes requiring dose adjustment and discontinuation and the most serious toxicity is interstitial lung disease, which occurs in about 1% of patients treated with EGFR receptor TKIs and is fatal in 30% who develop this toxicity. Conclusion: The EGFR receptor TKIs are an effective therapy in EGFR-mutated NSCLC and are recommended as first-line therapy for those with advanced or metastatic disease.
    Type of Medium: Online Resource
    ISSN: 1078-1552 , 1477-092X
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2012
    detail.hit.zdb_id: 2026590-6
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    SAGE Publications ; 2007
    In:  Journal of Oncology Pharmacy Practice Vol. 13, No. 1 ( 2007-03), p. 33-37
    In: Journal of Oncology Pharmacy Practice, SAGE Publications, Vol. 13, No. 1 ( 2007-03), p. 33-37
    Abstract: Objectives. To determine the stability of a compounded 50% ethanol solution (v/v) in syringes used for ethanol locks for central venous catheters. Design. Syringes were compounded with 50% ethanol solution (v/v) and were tested for ethanol concentration over a 28 day period. Syringes were stored at room temperature not protected from light and assayed on days 0, 1, 2, 3, 6, 7, 10, 15, 17, 21, and 28. Ethanolic content was determined using gas chromatography/flame ionization detection (GC/ FID) Varian CP-WAX58 (FFAP) CB capillary column. Setting. University of Wisconsin Comprehensive Cancer Center. Results. The mean value for all samples over 28 days was found to be 47.08% with a standard deviation of 2.72. Mean ethanol concentrations ranged from 43 to 52% over the 28 day period and did not vary with time. Conclusions. Ethanol is an effective disinfectant against a broad range of micro-organisms, including bacteria and fungi. Retrospective trials have suggested that the efficacy of an ethanol lock solution is superior to systemic antibiotics to treat and/or prevent central line venous infections; however, there is not a commercially available pharmaceutical product and ethanol 50% solutions are currently compounded. These findings suggest that a 50% (v/v) ethanol solution stored in a syringe at room temperature, not protected from light is stable over a 28 day period. J Oncol Pharm Practice (2007) 13: 33–37.
    Type of Medium: Online Resource
    ISSN: 1078-1552 , 1477-092X
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2007
    detail.hit.zdb_id: 2026590-6
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    SAGE Publications ; 2008
    In:  Journal of Oncology Pharmacy Practice Vol. 14, No. 1 ( 2008-03), p. 61-63
    In: Journal of Oncology Pharmacy Practice, SAGE Publications, Vol. 14, No. 1 ( 2008-03), p. 61-63
    Abstract: Hydroxyurea (HU) is a ribonucleotide reductase inhibitor used to treat myeloproliferative diseases including polycythemia vera (PV) and essential thrombocythemia (ET). We describe an 82-year-old male who was started on HU 500 mg three times weekly for the treatment of PV. Eight days after initiation of HU he experienced anorexia, nausea, vomiting, fever, fatigue, dizziness, and shaking chills. Discontinuation of the HU resulted in resolution of his symptoms within 2 days, and HU was re-started. Ten days after re-starting HU, the patient re-presented with nausea and anorexia. Lab tests revealed elevations in liver enzyme function tests, which resolved promptly after cessation of HU. Patients being initiated on HU should be advised that rarely, fevers, chills, nausea, and elevations in liver function tests may occur. J Oncol Pharm Practice (2008) 14: 61—63.
    Type of Medium: Online Resource
    ISSN: 1078-1552 , 1477-092X
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2008
    detail.hit.zdb_id: 2026590-6
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...